Showing results (371-380 of 436) with videos related to
Sort By:
Pageof 44
The Journal of Biological Chemistry|March 4, 2023
Structural analysis of the P132L disease mutation in caveolin-1 reveals its role in the assembly of oligomeric complexesBing Han, Alican Gulsevin, Sarah Connolly, et al.Neurology|May 5, 2021
Familial Autonomic Ganglionopathy Caused by Rare CHRNA3 Genetic VariantsCyndya A Shibao, Karen Joos, John A Phillips, et al.Proceedings of the National Academy of Sciences of the United States of America|July 21, 2026
Classification models for KCNQ1 variants distinguish functional and trafficking effects to enhance pathogenicity interpretationAna C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.Nature Communications|June 8, 2022
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individualsNina G Bozhanova, Andrew I Flyak, Benjamin P Brown, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretationAna C Chang-Gonzalez, Eric W Bell, Carlos G Vanoye, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.Science Advances|September 15, 2016
Structural basis for KCNE3 modulation of potassium recycling in epitheliaBrett M Kroncke, Wade D Van Horn, Jarrod Smith, et al.Nature Communications|September 19, 2025
Transient ligand contacts of the intrinsically disordered N-terminus of neuropeptide Y2 receptor regulate arrestin-3 recruitmentAnette Kaiser, Juan C Rojas Echeverri, Asat Baischew, et al.Science (New York, N.Y.)|November 16, 2023
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assemblyXiaojun Shi, Ryan Lingerak, Cameron J Herting, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2019
On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating MutationBenjamin P Brown, Yun-Kai Zhang, David Westover, et al.Pageof 44